Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NOS3 |
| Upstream (Parents) |
|---|
| (<<) IL32 → NOS3 |
| (<<) PROCR → NOS3 |
| (<<) BIN1 → NOS3 |
| (<<) COX5A → NOS3 |
| (<<) SMAD3 → NOS3 |
| (<<) RGS6 → NOS3 |
| (<<) ITGA4 → NOS3 |
| Downstream (Children) |
|---|
| NOS3 → PTPN20A///PTPN20B (>>) |
| NOS3 → FAM5C (>>) |
| NOS3 → PNLIP (>>) |
| NOS3 → CBLB (>>) |
| NOS3 → MLC1 (>>) |
| NOS3 → MC2R (>>) |
| NOS3 → COX5A (>>) |
| NOS3 → SMAD3 (>>) |
| NOS3 → SIX1 (>>) |
| NOS3 → NOS1 (>>) |
| NOS3 → C1orf14 (>>) |
